Tramadol carries a deceptively safe reputation, but for people over 65, it poses a tangle of risks that go well beyond what you’d expect from a “mild” painkiller. The drug’s unusual chemistry, which blends opioid activity with antidepressant-like effects on brain chemicals, creates a wider range of adverse reactions in aging bodies than most other pain medications. These include heightened fracture risk, dangerous drops in blood sugar and sodium, seizures, delirium, and a withdrawal syndrome that can blindside both patients and doctors. Older adults account for a disproportionate share of tramadol-related emergency visits and hospitalizations, and the reasons why run deeper than just “take a lower dose.”
A Painkiller With Two Mechanisms, Not One
Most opioid painkillers work in a fairly straightforward way: they bind to opioid receptors in the brain and spinal cord to dampen pain signals. Tramadol does that too, but it also blocks the reuptake of serotonin and norepinephrine, two neurotransmitters involved in mood, alertness, and pain modulation.1PubMed. Clinical pharmacology of tramadol This dual action is exactly what makes it look attractive on paper for older adults with chronic pain, since theoretically it can treat pain at lower opioid doses. In practice, though, having two separate pharmacological pathways means two separate sets of side effects and two separate categories of dangerous drug interactions.
The serotonin-boosting half of tramadol is the source of many of its most distinctive dangers for older adults, because this population takes antidepressants at high rates. The opioid half, meanwhile, still causes the typical opioid problems like respiratory depression, constipation, and physical dependence. Tramadol is not a gentler version of an opioid so much as an opioid stapled to a serotonergic drug, and in older bodies that process medications more slowly, both halves linger longer.
Aging Changes How the Drug Moves Through Your Body
Tramadol relies on the liver enzyme CYP2D6 to convert it into its active metabolite, called O-desmethyltramadol or M1. This metabolite is the part that does most of the heavy opioid lifting. In older adults, kidney function tends to decline, which directly affects how quickly both tramadol and M1 are cleared from the bloodstream. A pharmacokinetic study comparing older and younger adults found that in the elderly group, the active metabolite M1 accumulated to levels about 35% higher, while its elimination rate dropped by roughly a third.2PubMed. Pharmacokinetics of Tramadol and O-Desmethyltramadol Enantiomers Following Administration of Extended-Release Tablets to Elderly and Young Subjects Higher kidney clearance rates were associated with lower peak drug concentrations and shorter half-lives, which means that the worse your kidneys work, the more tramadol hangs around.3PubMed Central. Population Pharmacokinetic Model for Tramadol and O-desmethyltramadol in Older Patients
The practical implication is that a dose that would be in and out of a 30-year-old’s system in a few hours can build up in an older person over days, reaching concentrations the prescriber never intended. And because many of tramadol’s most dangerous effects are concentration-dependent, this slow accumulation is not just a pharmacological curiosity. It is the mechanism behind a surprising number of emergency department visits.
Falls and Hip Fractures
Hip fractures in older adults are a major cause of disability and death, and tramadol appears to raise this risk more than several common alternatives. A large population-based study found that people who started tramadol had a higher rate of hip fracture than those who started codeine, naproxen, ibuprofen, or celecoxib. Compared to codeine, tramadol carried about a 28% higher risk; compared to common anti-inflammatory drugs, the risk was 65% to 96% higher depending on the specific comparator.4PubMed Central. Association of Tramadol Use With Risk of Hip Fracture That is a striking finding, because many treatment guidelines have historically recommended tramadol as a safer alternative to anti-inflammatories for older adults with joint pain.
The fracture risk is not uniform across the older population. A study focused on people with post-traumatic osteoarthritis found the risk was especially pronounced among those aged 60 to 70, where tramadol users had roughly double the hip fracture risk, and among men, where the hazard was about 83% higher.5PubMed Central. Tramadol May Increase Risk of Hip Fracture in Older Adults with Post-Traumatic Osteoarthritis A separate nationwide case-control study of opioid use and hip fracture requiring surgery found that the association was strongest among men aged 65 to 69, with odds ratios exceeding five.6PubMed Central. Association of benzodiazepine and opioid use with hip fracture treated with arthroplasty: a nationwide case-control study
The likely culprits are tramadol’s ability to cause dizziness, sedation, and impaired balance, all of which matter enormously in an age group already prone to falling. For someone whose bones are already weakened by osteoporosis, even a modest increase in fall frequency can translate into a serious fracture.
Serotonin Syndrome and Seizures
Because tramadol inhibits serotonin reuptake, combining it with antidepressants that also raise serotonin levels can tip the balance into serotonin syndrome, a condition marked by agitation, rapid heartbeat, high blood pressure, fever, tremor, and in severe cases, muscle rigidity and organ failure. The combination of SSRIs or SNRIs with opioids like tramadol shows an exceptionally strong pharmacovigilance signal for serotonin syndrome.7PubMed Central. Serotonin syndrome risk with concomitant opioid and serotonergic antidepressant use: a multinational pharmacovigilance study While the overall incidence is low and most cases are mild to moderate, the syndrome can become life-threatening, and it is far easier to prevent than to treat once it starts.8PubMed Central. Interaction between tramadol and selective serotonin reuptake inhibitors: are doctors aware of potential risks in their prescription practice?
One illustrative case involved a 58-year-old woman taking venlafaxine (an SNRI) for depression and tramadol for nerve pain. When her antidepressant dose was increased, she developed tremor, exaggerated reflexes, diarrhea, racing heart, high blood pressure, and fever, meeting the clinical criteria for serotonin syndrome.9PubMed Central. Serotonin Syndrome With Concomitant Antidepressant and Tramadol: A Case Report This scenario is not exotic. Depression is common in older adults with chronic pain, and many are already on an SSRI or SNRI when tramadol is prescribed.
The drug interaction problem extends beyond serotonin syndrome into seizure risk. A study of older nursing home residents found that taking tramadol together with antidepressants that inhibit the CYP2D6 enzyme was associated with a higher risk of seizures.10PubMed Central. Risk of Seizure Associated With Concomitant Use of Tramadol and Antidepressants in Older Nursing Home Residents Several common antidepressants, including fluoxetine, paroxetine, and bupropion, are CYP2D6 inhibitors. What happens pharmacologically is that the inhibitor slows down tramadol’s conversion to its active metabolite, causing the parent drug to accumulate. Since tramadol itself (not the metabolite) is the compound responsible for lowering the seizure threshold, higher parent-drug levels mean higher seizure risk.
Delirium and Confusion
Delirium, a sudden and fluctuating state of confusion, is one of the most feared complications of hospitalization in older adults, and tramadol appears to carry a special risk for triggering it. A systematic review comparing the delirium risk of different opioids found that tramadol and meperidine were associated with an increased risk of delirium, while morphine, fentanyl, oxycodone, and codeine were not, when compared to using no opioid at all.11PubMed Central. The Comparative Risk of Delirium with Different Opioids: A Systematic Review The serotonergic and noradrenergic actions of tramadol likely explain why it stands apart here. These neurotransmitter systems play important roles in attention and arousal, and disrupting them in a brain that is already aging or stressed by illness can push someone into delirium faster than a purely opioid drug would.
Case reports have documented delirium developing rapidly after tramadol administration, with symptoms resolving once the drug was stopped.12PubMed Central. Acute Delirium due to Parenteral Tramadol In hospital settings, this can easily be misattributed to the patient’s underlying medical condition, especially if the treating team is not thinking of tramadol as a high-risk medication for cognitive disturbance.
Blood Sugar Drops and Sodium Imbalances
Two metabolic side effects of tramadol that rarely make it onto the patient information leaflet in bold print are hypoglycemia and hyponatremia. Both are more dangerous in older adults, and both can mimic other conditions, making them easy to miss.
Tramadol has a distinctive association with low blood sugar that other opioids largely do not share. A pharmacovigilance analysis found that tramadol-related hypoglycemia reports were more than 11 times higher than what would be expected from the opioid class as a whole, pointing to a mechanism specific to tramadol rather than a generic opioid effect.13PubMed Central. Retrospective analysis reveals significant association of hypoglycemia with tramadol and methadone in contrast to other opioids In a cohort study of diabetic patients, those taking tramadol had about a 32% higher risk of hypoglycemic episodes over two years of follow-up compared to non-users.14PubMed Central. Association of Tramadol and Hypoglycemia in Diabetic Asians Older adults are especially vulnerable because frail, elderly patients already have less metabolic reserve, and the symptoms of low blood sugar, such as confusion, shakiness, and dizziness, overlap heavily with side effects attributed to the drug itself or to aging.15JCEM Case Reports. Insulinoma Mimic: Tramadol-induced Hypoglycemia
Hyponatremia, or dangerously low sodium levels, is the other metabolic concern. Tramadol can trigger the inappropriate release of antidiuretic hormone, causing the kidneys to retain too much water and dilute the blood’s sodium concentration.16PubMed Central. Risk of Hyponatremia after Tramadol/Acetaminophen Single-Pill Combination Therapy: A Real-World Study Based on the OMOP–CDM Database A Swedish population study found that newly initiated tramadol therapy was associated with more than double the odds of hospitalization for severe hyponatremia, though the risk appeared to decrease once the body adjusted to ongoing treatment.17European Journal of Internal Medicine. Tramadol- and codeine-induced severe hyponatremia: A Swedish population-based case-control study Severe hyponatremia causes confusion, seizures, and can be fatal. In older adults already taking diuretics or eating less, the margin for error is very thin.
Respiratory Depression and the Polypharmacy Problem
Tramadol has long been marketed as having a lower risk of respiratory depression than stronger opioids, and at standard doses in healthy adults, that claim has some truth to it. But the risk changes sharply when other central nervous system depressants enter the picture. An analysis of the global pharmacovigilance database found that among tramadol-related respiratory depression cases, roughly 20% to 31% of patients were simultaneously taking other drugs known to increase that risk, such as benzodiazepines, other opioids, or antidepressants. This rate was four to seven times higher than in patients using tramadol without respiratory complications.18PubMed Central. Risk Factors for Respiratory Depression Associated with Tramadol Based on the Global Pharmacovigilance Database (VigiBase)
Older adults are the age group most likely to be taking multiple medications simultaneously. One trend worth noting is the rising concurrent use of tramadol with gabapentinoids like gabapentin and pregabalin. Among older adults, the proportion using both tramadol and a gabapentinoid together rose from about 28% to 33% between 2011 and 2018.19PubMed Central. Concurrent Use of Prescription Opioids and Gabapentinoids in Older Adults Gabapentinoids add their own sedating effects, and the combination amplifies the risk of oversedation and breathing problems. Many older patients arrive at a pain clinic already on a benzodiazepine for anxiety and an antidepressant for mood. Adding tramadol to that mix creates a cocktail of interacting drugs that the prescriber may not fully appreciate, especially when different specialists are prescribing different pieces of the puzzle.
Withdrawal That Does Not Look Like Typical Opioid Withdrawal
One of the more insidious aspects of tramadol is its withdrawal profile. Stopping the drug abruptly can produce classic opioid withdrawal symptoms such as sweating, muscle aches, nausea, and restlessness. But in a meaningful minority of cases, the withdrawal looks nothing like a typical opioid withdrawal. Reported atypical symptoms include hallucinations, paranoia, extreme anxiety, panic attacks, confusion, and unusual sensory experiences like numbness and tingling. An analysis of adverse event reports found that withdrawal symptoms of either type accounted for nearly 40% of all adverse events associated with chronic tramadol use, and about one in eight of those cases presented as atypical.20PubMed. Physical dependence on Ultram (tramadol hydrochloride): both opioid-like and atypical withdrawal symptoms occur
These atypical symptoms are thought to stem from tramadol’s serotonin and norepinephrine effects, not its opioid activity. For older adults, this matters because if a hospitalized patient has their tramadol abruptly discontinued (which happens often when medication lists are reconciled during an admission), the resulting hallucinations or paranoia may be attributed to dementia, delirium from infection, or psychiatric illness rather than recognized as drug withdrawal. A case report of a 68-year-old woman who had been on tramadol for over a decade and then stopped abruptly described unusual symptoms including significant mucus production, chest fullness, and neck soreness, none of which would normally be associated with opioid withdrawal.21PubMed. Atypical Withdrawal Symptoms after Abrupt Tramadol Discontinuation: A Case Report Tramadol should not be considered a “safer” opioid simply because it is a Schedule IV controlled substance.
The Emergency Room Numbers
Federal data from the United States paints a stark picture of who actually ends up in the emergency department because of tramadol. In 2011, patients aged 65 and older accounted for about 35% of all tramadol-related emergency visits involving adverse reactions. More striking, this age group made up 52% of the visits that were serious enough to require hospital admission or transfer to another facility.22Substance Abuse and Mental Health Services Administration. Emergency Department Visits for Adverse Reactions Involving the Pain Medication Tramadol Older adults are not just more likely to have a bad reaction to tramadol. When they do, they are more likely to end up being hospitalized for it.
How Genetic Variation Makes Things Less Predictable
The CYP2D6 enzyme that converts tramadol to its active metabolite varies enormously from person to person based on genetics. Some people are “ultrarapid” metabolizers who produce far more of the active metabolite than intended, while “poor” metabolizers produce very little and may get inadequate pain relief but still accumulate the parent drug. A study of post-surgical patients confirmed that poor and intermediate metabolizers had significantly lower concentrations of the active metabolite than normal or ultrarapid metabolizers.23PubMed Central. Impact of CYP2D6 and CYP2B6 phenotypes on the response to tramadol in patients with acute post-surgical pain
For older adults, this genetic variability compounds the age-related pharmacokinetic changes already discussed. An ultrarapid metabolizer in their 70s with declining kidney function might generate high levels of the active opioid metabolite and then struggle to clear it, creating prolonged respiratory depression or oversedation. A poor metabolizer on the same dose might get little pain relief but still face the seizure and serotonin-related risks from the parent drug building up. Genetic testing for CYP2D6 status exists and is increasingly available, but it is rarely ordered before tramadol is prescribed.
Bowel and Bladder Effects
Constipation from opioids is often dismissed as a mere nuisance, but in older adults it can become a genuine medical problem. Opioids, including tramadol, act on receptors in the gut wall to slow motility, reduce secretions, and increase sphincter tone. This combination delays transit through the entire gastrointestinal tract and can lead to hard stools, straining, fecal impaction, and in severe cases bowel obstruction.24PubMed Central. Management of Opioid-Induced Constipation and Bowel Dysfunction: Expert Opinion of an Italian Multidisciplinary Panel Older adults are already prone to constipation from reduced physical activity, lower fluid intake, and other medications like calcium channel blockers or iron supplements. Adding tramadol to this baseline often tips the balance into clinically significant bowel dysfunction.
Urinary retention is a less well-known side effect, but it has been documented in pharmacovigilance reports. Cases of transient bladder dysfunction and inability to urinate have been reported in association with tramadol use, resolving promptly after the drug was stopped.25Pharmacoepidemiology and Drug Safety. Bladder dysfunction during the use of tramadol For older men who may already have an enlarged prostate restricting urine flow, this effect can turn a manageable condition into an acute emergency requiring catheterization.
What the Guidelines Say and Why Perception Lags Behind
The American Geriatrics Society’s Beers Criteria, which lists medications considered potentially inappropriate for older adults, includes categories of drugs that should be avoided or used with caution in this population.26PubMed Central. American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults Yet tramadol continues to be widely prescribed to older people, partly because of a lingering perception that it is fundamentally different from “real” opioids. Its Schedule IV classification in the United States (compared to Schedule II for drugs like oxycodone) reinforces this impression. For years, many clinicians treated tramadol as essentially a strong version of acetaminophen rather than a true opioid, and that framing has been slow to change.
European pain management guidelines recommend starting with non-opioid options like acetaminophen and anti-inflammatory drugs for mild to moderate pain in older adults, with options like nefopam and metamizole as alternatives before reaching for any opioid.27PubMed Central. Pharmacological Pain Treatment in Older Persons When opioids are necessary, the choice of which one to use should factor in the patient’s complete medication list, kidney function, genetic background if known, and the specific side-effect profile of each option. Given the evidence on fractures, delirium, serotonin syndrome, seizures, hypoglycemia, and hyponatremia, the case for choosing tramadol as the default “safe” opioid for older patients has eroded considerably. The drug is not inherently worse than every alternative in every situation, but the assumption that it is inherently gentler no longer holds up.